Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Screening of 56 Herbal formulas covered by the National Health Insurance Service on Dementia-related Factors

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2018, v.39 no.3, pp.1-16
https://doi.org/10.13048/jkm.18020





  • Downloaded
  • Viewed

Abstract

Objectives: The aim of this study is to introduce the WFME Global Standards and Recognition process and to consider Improvement direction of Korean traditional medical curriculum. Methods: To Investigate the Standards and Recognition process of WFME and the traditional medical curriculum of each country(China, Taiwan, Japan, Korea). Results: The WFME Global Standards and Recognition process aims to train doctors who are educated and active in world standard medical Curriculum. The traditional medical colleges have not received recognition, but those colleges in Korea, China and Taiwan contain a lot of standards contents, and they need to be recognized if they belong to WDMS. Conclusions: Korea University of Oriental Medicine has a lot of subjects of WFME Standards and there is a medical education recognition association, which is advantageous for the standardization process of world medical education. Therefore, it is necessary to aim at world standard medicine while preserving the tradition of Oriental medicine, WFME Global Standards should be used to reorganize the curriculum and train a world-class medical professional.

keywords
WFME, Global Standards, Korean Medicine Education, Medical Education, Curriculum


Reference

1

1. Son CH, Kim YH, Lim S. A Study on Korean Oriental Medical Doctors’ Use of Uninsured Herbal Extracts and How to Promote the Insurance Coverage of Such Herbal Extracts. J Korean Oriental Med. 2009;30(4):64-78.

2

2. Burns A1, Iliffe S. Dementia. BMJ. 2009;338:b75.

3

3. Akhondzadeh S, Abbasi SH. Herbal medicine in the treatment of Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2006;21(2):113-8.

4

4. Cho HY, Hong SS, Whang WW, Cho SH. A Retrospective Study on Dementia Outpatients in Oriental Neuropsychiatry Clinic of One Medical Center. J of Oriental Neuropsychiatry. 2010;21(4):137-49.

5

5. Kim BG, Hyun KC, Kim JW, Whang WW. A Clinical Study on the Effects of Oriental Medical Treatment on Dementia of Alzheimer type. J of Oriental Neuropsychiatry. 1998;9(1);25-43.

6

6. Terasawa K, Shimada Y, Kita T, Yamamoto T, Tosa H, Tanaka N, et al. Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study. Phytomedicine. 1997;4(1):15-22.

7

7. Matsuda Y, Kishi T, Shibayama H, Iwata N. Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials. Hum Psychopharmacol. 2013;28(1):80-6.

8

8. Lim HS, Kim Y, Kim OS, Jeong SJ. Screening of 50 Korean Herbal formulas with Inhibitory Effects on Acetylcholinesterase Activity and Amyloid-β Aggregation. Kor J Pharmacogn. 2016;47(3):287-294.

9

9. Ministry of Health and Welfare Notice. No. 2014-56. 2014 Apr 18.

10

10. Lim HS, Ha H, Seo CS, Jin SE, Kim Y, Jeon WY, et al. Comparative study on efficacies and ingredient contents of different solvent extracts of Insampaedok-san. Kor. J. Herbology. 2012:27(6):115-122.

11

11. Ellman GL, Courtney KD, Andres VJr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88-95.

12

12. Habtemariam S. The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer's disease therapy. Nat Prod Commun 2011:6(8):1089-90.

13

13. Hellstrand E, Boland B, Walsh DM, Linse S. Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem. Neurosci. 2010;1:13-8.

14

14. Lemkul JA, Bevan DR. Morin inhibits the early stages of amyloid β-peptide aggregation by altering tertiary and quaternary interactions to produce “off-pathway” structures. Biochemistry. 2012:51(30):5990-6009.

15

15. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol Med. 1999;26:1231-7.

16

16. Prince M, Ali GC, Guerchet M, Prina AM, Albanese E, Wu YT. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther. 2016;8(1):23.

17

17. Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med. 2008;148(5):379-97.

18

18. Naik RS, Hartmann J, Kiewert C, Duysen EG, Lockridge O, Klein J. Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice. J Pharm Pharm Sci. 2009;12:79-85.

19

19. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA. 1993;90:7915-7922.

20

20. Koo JS, Seo BI, Park JH, Roh SS. Analysis of papers on Oriental herbal medicines(prescriptions and herbs) for dementia. Kor J Herbology. 2010;25:131-137.

21

21. Kim W, Jeon W, Heo E, Park S, Han C. Literature review and suggestions: dementia clinical studies in Korean Oriental Medicine. Kor J Orient Med. 2011;17:39-46.

22

22. Vetrivel KS, Thinakaran G. Amyloidogenic processing of betaamyloid precursor protein in intracellular compartments. Neurology. 2006;66:S69-73.

23

23. Eikelenboom P, van Gool WA. Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J Neural Transm. 2004;111:281-94.

24

24. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases:mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 2003;304:1-7.

25

25. Ministry of Health and Welfare Notice. No. 2015-35. 2015 Feb 23.

26

26. Hsu YL, Kuo PI, Tzeng TF, Sung SC, Yen MH, Lin YT, et al. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. J Gastroenterol Hepatol. 2008;23:e290-9.

27

27. Lu J, Wang JS, Kong LY. Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds. J Ethnopharmacol. 2011;134:911-8.

28

28. Sasaki K, Sudo T, Kurusu T, Kiuchi T, Yoshizaki F. The mechanism of alteration of monoamine metabolism in brain regions in marble burying behavior-isolated housing mice and effect of oren-gedoku-to on this alteration. Yakugaku Zasshi. 2000;120(6):559-67.

29

29. Chung SY, Kim JW, Lee JR, Jang HH, Kim HT, Whang WW. The Effects of Whangryonghaedoktang on Morris Water Maze and Tyrosine Hydroxylase Expression in Ventral Tegmental Area and Locus Coeruleus of the Chronic Mild Stress Animal Model of Depression. J of Oriental Neuropsychiatry. 2003;14(1):1-16.

30

30. Guoxin DU, Shangqin LIU, Xiaoxi XIE, Li HE, Xiaoling ZHU, Wenyu RONG, et al. The efficacy of Huang-Lian-Jie-Du-Tang combined with chemotherapy for multiple myeloma. J Clinical Hematology. 2012;25(5):306-8.

31

31. Sao L, Goto K, Shimada Y, Terasawa Y. Clinical comparative study of Huangyang detoxification hot water boiled rhubarb and atorvastatin for hyperlipidemia: including diet control, comparison with Placebo. Japan Toyo Kagaku Journal. 2004;55:236.

32

32. Tohru S. Significance of Combined Use of Huangyaku Toxin for Insomnia in Manic Condition. Journal of Japan Toyo Medical Journal. 2004;55:179.

33

33. Kim HY, Shin SH, Lee I. Neuroprotective Effect of Hwangryunhaedok-tang Against Glucosedeprivation Induced Cytotoxicity in PC-12 Cells. Korean J Oriental Physiology & Pathology. 2008;22(6):1462-9.

34

34. Qing F, Xiaoping Z, Jianwei M, Mei S. The therapeutic effect of Huanglian Jiedu Decoction on AD rats and its effect on cytokine content. J of Tradit Chin Med. 2004;29(6):575-8.

35

35. Qiu Y, Chen G, Mei G, Wang W, Wang K, Pan S. Effect of Huanglian Jiedu Decoction on free radical metabolism and IL-6, IL-1β content in brain tissue of mice with APP/PS1 double transgenic Alzheimer's disease. Stroke and neurological diseases. 2011;18(2):72-4.

36

36. Chen G, Shan P, Qiu Y. Clinical study of Huanglian Jiedu Decoction in the treatment of senile dementia (Heart and Liver). Chinese Journal of Emergency Medicine. 2007;16(4):386-7.

37

37. Ministry of Health and Welfare Notice. No. 2017-214. 2017 Nov 27.

38

38. Lee JY, Kook YB. Effects of Samhwangsasimtang on obesity-related metabolic disease in mice. Herbal formula science. 2014;22(1):93-104.

39

39. Lee HC, Jeong MY, Choi JH, Park SY. Effects of Samhwangsasim-tang Gamibang on Atopic Dermatitis in Mice. Herbal formula science. 2017;25(3)337-47.

40

40. Koo JS, Kwon DK, Seo BI, Park JH, Roh SS, Kim SM, et al. The Antimicrobial Activity of Samhwangsasimtang against pseudomonas aeruginosa 38 isolated from an acne patient. Kor J Herbology. 2010;25(2):11-9.

41

41. Seok SH, Kim JH, Kim GW, Koo BS. A case of insomnia incurable by neuropsychiatric medication alone, but made possible with Sam-Hwang-Sa-Sim-Tang. J of Oriental Neuropsychiatry. 2006;17(3):117-29.

42

42. Shin SU, Lee JS, Kim SS. Effect of modified Samhwangsasim-tang(三黃瀉心湯加味方) on Suspicious Dementia of Multiple Infarction Induced by Hypoxia: A Case ReportJ Oriental Rehab Med. 2001;11(2):219-26

상단으로 이동

Journal of Korean Medicine